| 000 | 00906 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517123232.0 | ||
| 264 | 0 | _c20170713 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a1474-1784 | ||
| 024 | 7 |
_a10.1038/nrd.2016.188 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCassidy, Sorcha | |
| 245 | 0 | 0 |
_aNonalcoholic steatohepatitis (NASH) drugs market. _h[electronic resource] |
| 260 |
_bNature reviews. Drug discovery _cNov 2016 |
||
| 300 |
_a745-746 p. _bdigital |
||
| 500 | _aPublication Type: News | ||
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 | _aDrug Industry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNon-alcoholic Fatty Liver Disease _xdrug therapy |
| 700 | 1 | _aSyed, Basharut A | |
| 773 | 0 |
_tNature reviews. Drug discovery _gvol. 15 _gno. 11 _gp. 745-746 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrd.2016.188 _zAvailable from publisher's website |
| 999 |
_c26572055 _d26572055 |
||